FIELD: medicine. SUBSTANCE: invention relates to the enhancement of resistance against acute hypobaric hypoxia. For this aim 6,8-dimethyl-2- piperidinomethyl-2,3-dihydrothiazolo-[2,3-f] -xanthine showing novel antihypoxic properties is used. Invention ensures to provide the high therapeutic activity and decrease of adverse effects of treatment. EFFECT: enhanced effectiveness of agent. 1 cl, 2 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
HYDROCHLORIDE ENHANCING RESISTANCE AGAINST ACUTE HYPOXIA WITH HYPERKAPNIA | 2002 |
|
RU2225867C1 |
1-ALKENYLIMIDAZOLE DERIVATIVES | 2008 |
|
RU2397175C1 |
ZINC ACETATE COMPLEX WITH 3-HYDROXYPYRIDINE WITH ANTI-HYPOXIC ACTIVITY UNDER CONDITIONS OF ACUTE EXOGENOUS HYPOXIA | 2016 |
|
RU2631496C1 |
COMPLEX OF ZINC ACETATE WITH 1-PROPARGYLIMIDAZOL WITH ANTI-HYPOXIC ACTIVITY | 2016 |
|
RU2632682C1 |
1-ALLYLIMIDAZOLE DERIVATIVES | 2009 |
|
RU2430090C2 |
3-(N,N-DIMETHYLCARBAMOYLHYDROXY)-2-ETHYL-6-METHYLPYRIDINE SUCCINATE SHOWING ANTIHYPOXIC ACTIVITY | 1993 |
|
RU2095350C1 |
2-[2-(DIETHYLAMINO) -ETHYLTHIO]-5,6- DIMETHYLBENZIMIDAZOLE SALTS SHOWING ANTIISCHEMIC, ANTIHYPOXIC AND ANTIARRHYTHMIC ACTIVITY AND 2-[2-(DIETHYLAMINO) -ETHYLTHIO]-5,6- DIMETHYLBENZIMIDAZOLE AS AN INTERMEDIATE PRODUCT FOR SYNTHESIS OF 2-[2-(DIETHYLAMINO) -ETHYLTHIO] -5,6-DIMETHYLBENZIMIDAZOLE SALTS | 1991 |
|
RU2027709C1 |
COMPLEX COMPOUND 1,3-BIS(2-HYDROXYETHYL)-5-HYDROXY-6-METHYLURACIL WITH FUMARIC ACID THAT EXHIBITS ANTI-HYPNOTIC ACTIVITY AND METHOD OF OBTAINING IT | 2006 |
|
RU2330025C2 |
COMPLEX COMPOUND OF 6-METHYLURACIL WITH SUCCINIC ACID ELICITING ANTIHYPOXIC ACTIVITY AND METHOD FOR ITS PREPARING | 2003 |
|
RU2259357C2 |
DRUG POSSESSING ANTIHYPOXIC, ACTOPROTECTIVE, NOOTROPIC ACTIVITIES AND HAVING EFFECT ON PHYSICAL EFFICIENCY, AND BASED PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2462245C1 |
Authors
Dates
2002-10-20—Published
2001-07-06—Filed